Physician profile
Anitha Garlapati
NPI 1477641967
$419.79
in general payments reported to CMS, 2019-2025
9 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $46.65 · 2022: $37.09 · 2024: $84.49 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $135.23 | 2019-2024 | Xarelto |
| Abbvie INC. | $52.83 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $52.37 | 2025 | Vowst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.92 | 2024-2025 | Ofev |
| Allergan, INC. | $46.12 | 2019-2020 | |
| Genzyme Corporation | $35.05 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.30 | 2019 | |
| Grifols USA, LLC | $18.15 | 2024 | Prolastin-C Liquid |
| E.R. Squibb & Sons, L.L.C. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anitha Garlapati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.